Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Korean Biotechs Relaunching IPOs After Withdrawals Last Year

This article was originally published in PharmAsia News

Executive Summary

South Korean companies that withdrew IPO plans late last year due largely to the crowded year-end offering market are now returning. Among them are drug developers Anterogen and Qurient, which successfully relaunched floats in the second-tier Kosdaq market in February.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register